脐血来源或自体细胞因子诱导的杀伤细胞联合干扰素治疗慢性乙型肝炎的安全性和有效性分析
目的观察应用脐血和自体细胞因子诱导的杀伤细胞（CIK细胞）联合干扰素治疗慢性乙型肝炎（CHB）的安全性和有效性。方法 30例CHB患者均为解放军第一○五医院感染科2010年10月-2013年6月住院患者,签署临床实验研究入组同意书后随机分为3组,每组10例,治疗组分别给予脐血或自体CIK细胞移植,同时给予干扰素治疗,对照组仅接受干扰素治疗,观察治疗后4、12周患者外周血ALT、HBV血清学标志物（HBV M）、HBV DNA对数值和CD4＋/CD8＋水平的变化。两样本均数比较采用配对t检验或成组t检验。结果脐血或自体CIK细胞移植后12周,患者外周血ALT、HBeAg、HBV DNA对数值分别...
Saved in:
| Published in | 临床肝胆病杂志 Vol. 30; no. 9; pp. 869 - 872 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
解放军第一0五医院 感染科,合肥,230031
2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1001-5256 |
| DOI | 10.3969/j.issn.1001-5256.2014.09.008 |
Cover
| Abstract | 目的观察应用脐血和自体细胞因子诱导的杀伤细胞（CIK细胞）联合干扰素治疗慢性乙型肝炎（CHB）的安全性和有效性。方法 30例CHB患者均为解放军第一○五医院感染科2010年10月-2013年6月住院患者,签署临床实验研究入组同意书后随机分为3组,每组10例,治疗组分别给予脐血或自体CIK细胞移植,同时给予干扰素治疗,对照组仅接受干扰素治疗,观察治疗后4、12周患者外周血ALT、HBV血清学标志物（HBV M）、HBV DNA对数值和CD4＋/CD8＋水平的变化。两样本均数比较采用配对t检验或成组t检验。结果脐血或自体CIK细胞移植后12周,患者外周血ALT、HBeAg、HBV DNA对数值分别为（22.6±14.4）和（32.9±15.3）U/L;（12.5±5.8）和（18.4±8.8）PEIU/ml;（3.2±0.7）和（3.7±0.6）,与对照组相比均明显降低（t=2.80～5.45,P〈0.05）。两治疗组治疗4周后CD4＋和CD4＋/CD8＋水平均较对照组明显升高（t=2.21～2.43,P〈0.05）;两组移植患者术中均未出现严重不良反应,无与移植相关的严重并发症发生。结论人脐血和自体CIK细胞移植治疗CHB,短期内可明显抑制病毒复制,改善患者肝功能和临床症状,并能提高患者细胞免疫水平,具有良好的安全性。 |
|---|---|
| AbstractList | 目的观察应用脐血和自体细胞因子诱导的杀伤细胞（CIK细胞）联合干扰素治疗慢性乙型肝炎（CHB）的安全性和有效性。方法 30例CHB患者均为解放军第一○五医院感染科2010年10月-2013年6月住院患者,签署临床实验研究入组同意书后随机分为3组,每组10例,治疗组分别给予脐血或自体CIK细胞移植,同时给予干扰素治疗,对照组仅接受干扰素治疗,观察治疗后4、12周患者外周血ALT、HBV血清学标志物（HBV M）、HBV DNA对数值和CD4＋/CD8＋水平的变化。两样本均数比较采用配对t检验或成组t检验。结果脐血或自体CIK细胞移植后12周,患者外周血ALT、HBeAg、HBV DNA对数值分别为（22.6±14.4）和（32.9±15.3）U/L;（12.5±5.8）和（18.4±8.8）PEIU/ml;（3.2±0.7）和（3.7±0.6）,与对照组相比均明显降低（t=2.80～5.45,P〈0.05）。两治疗组治疗4周后CD4＋和CD4＋/CD8＋水平均较对照组明显升高（t=2.21～2.43,P〈0.05）;两组移植患者术中均未出现严重不良反应,无与移植相关的严重并发症发生。结论人脐血和自体CIK细胞移植治疗CHB,短期内可明显抑制病毒复制,改善患者肝功能和临床症状,并能提高患者细胞免疫水平,具有良好的安全性。 R512.62; 目的：观察应用脐血和自体细胞因子诱导的杀伤细胞（CIK细胞）联合干扰素治疗慢性乙型肝炎（CHB）的安全性和有效性。方法30例CHB患者均为解放军第一0五医院感染科2010年10月-2013年6月住院患者，签署临床实验研究入组同意书后随机分为3组，每组10例，治疗组分别给予脐血或自体CIK细胞移植，同时给予干扰素治疗，对照组仅接受干扰素治疗，观察治疗后4、12周患者外周血ALT、HBV血清学标志物（HBV M）、HBV DNA对数值和CD4＋/CD8＋水平的变化。两样本均数比较采用配对t检验或成组t检验。结果脐血或自体CIK细胞移植后12周，患者外周血ALT、HBeAg、HBV DNA对数值分别为（22．6±14.4）和（32．9±15．3）U/L；（12．5±5．8）和（18．4±8．8）PEIU/ml；（3．2±0．7）和（3．7±0．6），与对照组相比均明显降低（t＝2．80～5．45，P＜0.05）。两治疗组治疗4周后CD4＋和CD4＋/CD8＋水平均较对照组明显升高（t＝2．21～2．43，P＜0．05）；两组移植患者术中均未出现严重不良反应，无与移植相关的严重并发症发生。结论人脐血和自体CIK细胞移植治疗CHB，短期内可明显抑制病毒复制，改善患者肝功能和临床症状，并能提高患者细胞免疫水平，具有良好的安全性。 |
| Abstract_FL | Objective To investigate the efficacy and safety of umbilical cord blood (UCB)-derived or autologous cytokine-induced killer (CIK)cells combined with interferon therapy in patients with chronic hepatitis B (CHB).Methods Thirty CHB patients hospitalized in the Department of Infectious Diseases from October 2010 to June 2013 were included in the study.These patients were randomly and equally divid-ed into first and second treatment groups and control group.The first or second treatment group underwent transplantation of UCB-derived or autologous CIK cells combined with interferon therapy;the control group received interferon therapy alone.At 4 and 12 weeks after treatment, alanine aminotransferase (ALT),serum hepatitis B virus (HBV)marker,HBV DNA,and CD4+/CD8 +ratio in peripheral blood were meas-ured.Comparison of means was made by paired t test or independent-samples t test.Results At 12 weeks after transplantation of UCB-de-rived or autologous CIK cells,the first or second treatment group had ALT,HBeAg,and HBV DNA levels of (22.6 ±14.4)or (32.9 ±15.3) U/L,(12.5 ±5.8)or (18.4 ±8.8)PEIU/ml,and (3.2 ±0.7)or (3.7 ±0.6)log10 copies/ml,respectively,significantly lower than those for control group (t=2.80~5.45,P<0.05).At 4 weeks after transplantation,the two treatment groups had significantly increased CD4+levels and CD4+/CD8 +ratios compared with the control group (t=2.21 ~2.43,P<0.05).No severe adverse reactions and transplantation-related severe complications were found in the two treatment groups.Conclusion For CHB patients,transplantation of UCB-derived or autologous CIK cells significantly inhibits virus replication rapidly,improves liver function,relieves clinical symptoms,improves cellular im-munity,and has high safety. |
| Author | 刘波 董静 张骏飞 宋海燕 陈从新 |
| AuthorAffiliation | 解放军第一〇五医院感染科,合肥230031 |
| AuthorAffiliation_xml | – name: 解放军第一0五医院 感染科,合肥,230031 |
| Author_xml | – sequence: 1 fullname: 刘波 董静 张骏飞 宋海燕 陈从新 |
| BookMark | eNo9kElLw1AUhd-iguOfEBduEu9L8l7yliJOUHDTfcnQ1Iim2iCibqpWTVEkOOLQUkVRBEfcOP2bvpf8DCMVV_dy7nfOgduNMn7JLyA0gEFWGWVDM7IXBL6MAbBEFEJlBbAmA5MBjAzq-tc7UV8QeBYQrFKmEdqFVpNqlFxWRP1GfEQiPE6271vfB_HnVrLR4OdN_hAlTy_86Ss-q4p6pfV13T4la4c8Cvn7q6g9x29N8foZH5-IzStRuW29n_LGTrJej9f3Uhd_rPHNu1Tn-7vioiaOwt893BKNqBd1uOZsUOj7mz0oNzaaG5mQslPjkyPDWcmmAJJJwVI1HZiLdaxQyrBNbEwtsCxddTRKXGwQgpnuEGIQwwXTVLFGiKVZUGDEUXvQYDt2yfRd0y_mZ0qLZT8tzM_aRcdaWfl9FjDAkKL9bdSeLvnFBS-F58venFlezlOq0LRIZ-oPiH-ZKg |
| ClassificationCodes | R512.62 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2014.09.008 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Efficacy and safety of UCB- derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B |
| DocumentTitle_FL | Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chro-nic hepatitis B |
| EndPage | 872 |
| ExternalDocumentID | lcgdbzz201409010 662618579 |
| GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c600-a60b34709f17126691c5c16b0bb73d465f1855197d55858f0aa31455b4b0e95d3 |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 03:59:49 EDT 2025 Wed Feb 14 10:36:34 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | 肝炎,乙型,慢性 杀伤细胞 干扰素Ⅱ型 hepatitis B,chronic killer cells interferon type |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c600-a60b34709f17126691c5c16b0bb73d465f1855197d55858f0aa31455b4b0e95d3 |
| Notes | LIU Bo, DONG Jing, ZHANG Junfei, et al. （Department of Infectious Diseases, 105 Hospital of PLA, Hefei 230031, China） hepatitis B; chronic; killer cells; interferon type Objective To investigate the efficacy and safety of umbilical cord blood（ UCB）- derived or autologous cytokine- induced killer（ CIK） cells combined with interferon therapy in patients with chronic hepatitis B（ CHB）. Methods Thirty CHB patients hospitalized in the Department of Infectious Diseases from October 2010 to June 2013 were included in the study. These patients were randomly and equally divided into first and second treatment groups and control group. The first or second treatment group underwent transplantation of UCB- derived or autologous CIK cells combined with interferon therapy; the control group received interferon therapy alone. At 4 and 12 weeks after treatment,alanine aminotransferase（ ALT）,serum hepatitis B virus（ HBV） marker,HBV DNA,and CD4＋/CD8＋ratio in peripheral blood were measured. Comparison of means was made by paired |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_lcgdbzz201409010 chongqing_primary_662618579 |
| PublicationCentury | 2000 |
| PublicationDate | 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014 |
| PublicationDecade | 2010 |
| PublicationTitle | 临床肝胆病杂志 |
| PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2014 |
| Publisher | 解放军第一0五医院 感染科,合肥,230031 |
| Publisher_xml | – name: 解放军第一0五医院 感染科,合肥,230031 |
| SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 1.9643711 |
| Snippet | 目的观察应用脐血和自体细胞因子诱导的杀伤细胞（CIK细胞）联合干扰素治疗慢性乙型肝炎（CHB）的安全性和有效性。方法 30例CHB患者均为解放军第一○五医院感染科2010年10... R512.62; 目的：观察应用脐血和自体细胞因子诱导的杀伤细胞（CIK细胞）联合干扰素治疗慢性乙型肝炎（CHB）的安全性和有效性。方法30例CHB患者均为解放军第一0五医院感染... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 869 |
| SubjectTerms | 干扰素Ⅱ型 杀伤细胞 肝炎,乙型,慢性 |
| Title | 脐血来源或自体细胞因子诱导的杀伤细胞联合干扰素治疗慢性乙型肝炎的安全性和有效性分析 |
| URI | http://lib.cqvip.com/qk/90100X/201409/662618579.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201409010 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate issn: 1001-5256 databaseCode: ABDBF dateStart: 20130401 customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn omitProxy: true ssIdentifier: ssj0041983 providerName: EBSCOhost – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources issn: 1001-5256 databaseCode: M~E dateStart: 19850101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://road.issn.org omitProxy: true ssIdentifier: ssib053243598 providerName: ISSN International Centre |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9RAEG8QEuKL8TMiajBhn8jhtt1udx7boxdigk-Y8Eau9wEP5vADXvAFERCiMRc_MH5A0Gg0JooSY4Lgf0N792c4s-0dNSFEfWnmtjPzm9lpu9Pe7qxh9EsBZjUM3ZxZwttNYMqeU7ZUOW6VTUwwpFXRm8GMXJXD18SVMWes48iPzKylmelwsDR74LqS_4kqtmFcaZXsP0S2rRQbkMb44hEjjMe_ijELFFOCASfCM2nWQiAZDDHPIcL39CnJlGIgNbPLPI8FgvlDDGwWuMz3mUpO2QwCFjgMfOZxIryhluYC803dgkSepMAj3ASLQAW1e-IghUiYDITWzMkSJHxgvqUNQ4JrKaFBJbWjBoJA5a7mQdyEmTPP1VjAALTCgClfQ1hkCUohoYKMhSgbEAoSpEdl9KA4Mue1F3nNg4SjLczw4E9yRxJWsuNoK5XXliiynDxCOC9jiXafBF3yQjmtvrI0c4FBe_hPQUDD-jb6OkDiYDIPAwQkBTCgxfK6j4BCqAqaoC4eaHnpaw3I5-qeQGRnQGsA7ZTQoQm0JcjHs997khW26eBE098cKynE3hq90n-1krsUMkORSrbAaWc11kEDpg0S9IBJAINtAJrymNT_5Wo_UWhP35T4Fkw1xOCI0WXRd7BOo8vzh_zCfiJu8j-qJNFy7cyLAu1yIDKFFB3TliD2qzo5mOZTaclWTiVMUMlSmdTAbqM_tf7yYbZTwZTJqdrETUwD9aq8WrVYm8gkkKPHjWPpm1-fl9zGJ4yO2cmTRvdIOrfllHGnuVBvvpmL197HP-vx8mrz_qe9X08aO0vNe-vRq43oc725-S3a3G28XIjX5vZ23yWnmnefRvXlaHsrXvna-L4Rb-00Vp_Hi2_juQ972y-i9QfN-bXG_COUir6sRIsfsT16_DB-vRI_WyZ6eSler582RgvBaH44l26NkivhG0quKHloC5dD1XRNTLHBLDklU4Ycn7p2WUiniuGhJellx8EwVHmxaNOOBKEIeQWcsn3G6KxN1SpnjT4oQlWVi7bkVSHKoQypYqdVUhKf28DLZo_R2-7C8RtJBZzx9gXQY1xKO3U8fS7eHr9emiiHs7MUBk6Tv84dqqHXOEqcyVfN80bn9K2ZygXM86fDi-lF9RswCc8Q |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%84%90%E8%A1%80%E6%9D%A5%E6%BA%90%E6%88%96%E8%87%AA%E4%BD%93%E7%BB%86%E8%83%9E%E5%9B%A0%E5%AD%90%E8%AF%B1%E5%AF%BC%E7%9A%84%E6%9D%80%E4%BC%A4%E7%BB%86%E8%83%9E%E8%81%94%E5%90%88%E5%B9%B2%E6%89%B0%E7%B4%A0%E6%B2%BB%E7%96%97%E6%85%A2%E6%80%A7%E4%B9%99%E5%9E%8B%E8%82%9D%E7%82%8E%E7%9A%84%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%88%98%E6%B3%A2+%E8%91%A3%E9%9D%99+%E5%BC%A0%E9%AA%8F%E9%A3%9E+%E5%AE%8B%E6%B5%B7%E7%87%95+%E9%99%88%E4%BB%8E%E6%96%B0&rft.date=2014&rft.issn=1001-5256&rft.volume=30&rft.issue=9&rft.spage=869&rft.epage=872&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2014.09.008&rft.externalDocID=662618579 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |